50090-1523
GARDASIL
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Human Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
INJECTION, SUSPENSION
Intramuscular
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
40.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN
40.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
20.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
20.0
ug/.5mL
50090-1523-01
10 VIAL, SINGLE-DOSE in 1 CARTON (50090-1523-1) > .5 mL in 1 VIAL, SINGLE-DOSE (50090-1523-9)
June 8, 2006

50090-1523-09
June 8, 2006
Ancillary Therapy
Protective Agent
HPV Vaccine
 
 
In Use